Regency Centers
REG Nasdaq Retail REITs Financials FY2016βFY2025
Regency Centers' revenue rose 6.8% to $1.6 billion in fiscal 2025. Its operating margin was 72.3%, up from 72.0% a year earlier. Free cash flow was $393 million, down 12.1%. It paid out $512 million in dividends and buybacks, 130% of free cash flow.
About these figures. Capital spending is Regency's real estate development and capital improvements line; acquisitions aren't included. Regency's filings from 2021 don't tag its average share count, so the change in diluted shares is blank from then; its filings before its 2017 merger with Equity One tag few figures, so 2016 is mostly blank.
What Regency Centers does
No business description yet.
- Legal name
- REGENCY CENTERS CORPORATION
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-051668
0000910606
Revenue and margins
Regency Centers had $1.6B of revenue in fiscal 2025, up 6.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $393M in fiscal 2025, 25.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Regency Centers returned $512M to shareholders in fiscal 2025, 130% of free cash flow. The diluted share count rose 0.0%.
Value Regency Centers yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$4.6B and divides by 0.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 25.4x Β· peers 20.1x Β· sector 28.2x.
Balance sheet
Cash, debt and the ratios that show how comfortably Regency Centers can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $95.0M | $68.8M | $91.4M | $61.9M | $121M |
| Debt incl. finance leases | $3.7B | $3.7B | $4.2B | $4.4B | $4.7B |
| Net debt / EBITDA | 4.7x | 3.0x | 3.1x | 3.0x | 3.0x |
| Debt / equity | 0.6x | 0.6x | 0.6x | 0.7x | 0.7x |
| Interest coverage | 3.2x | 6.1x | 6.2x | 6.5x | 6.3x |
| Total assets | $10.8B | $10.9B | $12.4B | $12.4B | $13.0B |
| Total liabilities | $4.7B | $4.7B | $5.2B | $5.5B | $5.8B |
| Shareholders' equity | $6.0B | $6.1B | $7.0B | $6.7B | $6.9B |
| Net debt (β = net cash) | $3.6B | $3.7B | $4.1B | $4.3B | $4.6B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$40.9M
6 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Terah L DevereauxPrincipal Accounting Officer | Sold | 1,240 | $80.14 | $0.1M | Form 4 |
| May 5, 2026 | Nicholas Andrew WibbenmeyerW. Regional Pres. & CIO | Sold | 7,927 | $79.06 | $0.6M | Form 4 |
| May 4, 2026 | Martin E Stein JrExecutive Chairman, Director | Sold | 274,615 | $78.40 | $21.5M | Form 4 |
| Mar 11, 2026 | Martin E Stein JrExecutive Chairman, Director | Sold | 38,000 | $77.21 | $2.9M | Form 4 |
| Mar 10, 2026 | Martin E Stein JrExecutive Chairman, Director | Sold | 129,490 | $78.33 | $10.1M | Form 4 |
| Feb 20, 2026 | Martin E Stein JrExecutive Chairman, Director | Sold | 10,000 | $76.30 | $0.8M | Form 4 |
| Feb 10, 2026 | Alan Todd RothE. Regional Pres. & COO | Sold | 8,000 | $77.05 | $0.6M | Form 4 |
| Feb 10, 2026 | Lisa PalmerPresident and CEO, Director | Sold | 26,000 | $76.75 | $2.0M | Form 4 |
| Feb 10, 2026 | Michael J MasEVP and CFO | Sold | 15,000 | $76.85 | $1.2M | Form 4 |
| Nov 10, 2025 | Martin E Stein JrExecutive Chairman, Director | Sold | 15,000 | $70.02 | $1.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β3.1% | β3.1% | β2.4% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Regency Centers REG | β | 6.9% | 72.3% | 25.3% | 7.7% | 25.4x | β | |
| Brixmor Property Group BRX | $8.7B | 6.7% | β | β | β | 20.1x | β | Compare β |
| Federal Realty Investment Trust FRT | $9.4B | 6.4% | 47.1% | β | 6.0% | 18.9x | β | Compare β |
| Kimco Realty KIM | $15.9B | 5.1% | 36.0% | β | 4.3% | 27.5x | β | Compare β |
| NNN Reit NNN | $7.8B | 6.6% | 63.6% | β | β | 20.2x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | β | $984M | $1.1B | $1.1B | $1.0B | $1.2B | $1.2B | $1.3B | $1.5B | $1.6B |
| Operating income | β | β | β | β | β | β | $897M | $951M | $1.0B | $1.1B |
| Interest expense | β | $133M | $149M | $151M | $157M | $145M | $146M | $154M | $161M | $179M |
| Pretax income | β | $126M | $209M | $182M | $13.1M | $319M | $428M | $320M | $360M | $408M |
| Income tax | β | β$9.6M | $0.5M | $1.2M | $1.3M | $1.0M | $0.0M | $0.9M | $4.5M | β |
| Net income | $167M | $176M | $249M | $239M | $44.9M | $361M | $483M | $365M | $400M | $528M |
| Diluted EPS | β | $1.00 | $1.46 | $1.43 | $0.26 | $2.12 | $2.81 | $2.04 | $2.11 | $2.82 |
| Diluted shares | β | 0.16B | 0.17B | 0.17B | 0.17B | β | β | β | β | β |
| Cash flow | ||||||||||
| Cash from operations | β | $470M | $610M | $621M | $499M | $659M | $656M | $720M | $790M | $828M |
| Capital expenditure | β | $347M | $226M | $200M | $181M | $178M | $195M | $233M | $343M | $435M |
| Free cash flow | β | $123M | $384M | $421M | $318M | $482M | $460M | $487M | $447M | $393M |
| Depreciation and amortization | β | $334M | $360M | $374M | $346M | $303M | $320M | $352M | $395M | $405M |
| Stock-based compensation | β | $20.5M | $13.6M | $14.3M | $13.6M | $12.5M | $16.5M | $20.1M | $23.5M | $19.5M |
| Acquisitions | $388M | $647M | $0.0M | $0.0M | $0.0M | $533M | $241M | $82.4M | $71.4M | $699M |
| Share buybacks | $0.0M | $0.0M | $214M | $32.8M | $0.0M | $0.0M | $75.4M | $20.0M | $200M | $0.0M |
| Dividends paid | $0.0M | $323M | $376M | $391M | $301M | $403M | $428M | $453M | $490M | $512M |
| Dividends and buybacks | $0.0M | $323M | $590M | $423M | $301M | $403M | $504M | $473M | $690M | $512M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $17.9M | $49.4M | $45.2M | $116M | $378M | $95.0M | $68.8M | $91.4M | $61.9M | $121M |
| Total debt | $1.6B | $3.6B | $3.7B | $3.9B | $3.9B | $3.7B | $3.7B | $4.2B | $4.4B | $4.7B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $4.1M | $6.1M | $6.1M | $7.1M | $6.6M | $5.4M | $5.8M | $6.7M | $8.0M | $12.7M |
| Total assets | β | β | $10.9B | $11.1B | $10.9B | $10.8B | $10.9B | $12.4B | $12.4B | $13.0B |
| Total liabilities | β | β | $4.5B | $4.8B | $4.9B | $4.7B | $4.7B | $5.2B | $5.5B | $5.8B |
| Shareholders' equity | $2.6B | $6.7B | $6.4B | $6.2B | $6.0B | $6.0B | $6.1B | $7.0B | $6.7B | $6.9B |
| Margins | ||||||||||
| Operating margin | β | β | β | β | β | β | 73.3% | 71.9% | 72.0% | 72.3% |
| EBITDA margin | β | 60.2% | 64.0% | 62.5% | 50.8% | 65.8% | 99.4% | 98.6% | 99.2% | 98.4% |
| Net margin | β | 17.9% | 22.2% | 21.1% | 4.4% | 31.0% | 39.5% | 27.6% | 27.5% | 34.0% |
| FCF margin | β | 12.5% | 34.3% | 37.2% | 31.3% | 41.3% | 37.6% | 36.8% | 30.7% | 25.3% |
| Returns | ||||||||||
| Return on capital | β | β | β | 3.3% | 1.6% | 4.8% | 9.2% | 9.0% | 9.2% | 7.7% |
| Return on equity | β | β | β | 3.8% | 0.7% | 6.0% | 8.0% | 5.6% | 5.8% | 7.7% |
| Return on assets | β | β | β | 2.2% | 0.4% | 3.3% | 4.5% | 3.1% | 3.2% | 4.2% |
| Growth | ||||||||||
| Revenue growth | β | β | 13.9% | 1.1% | β10.3% | 14.8% | 5.0% | 8.0% | 9.9% | 6.9% |
| Net income growth | 9.5% | 5.4% | 41.5% | β3.9% | β81.3% | 705.1% | 33.6% | β24.5% | 9.8% | 31.7% |
| EPS growth | β | β | 46.0% | β2.1% | β81.8% | 715.4% | 32.6% | β27.4% | 3.4% | 33.7% |
| FCF growth | β | β | 212.5% | 9.7% | β24.4% | 51.4% | β4.4% | 5.7% | β8.2% | β12.1% |
| Share count change | β | β | 6.3% | β1.4% | 1.0% | β | β | β | β | β |
| Financial health | ||||||||||
| Net debt / EBITDA | β | 6.0x | 5.1x | 5.4x | 6.9x | 4.7x | 3.0x | 3.1x | 3.0x | 3.0x |
| Debt / equity | β | β | 0.6x | 0.6x | 0.7x | 0.6x | 0.6x | 0.6x | 0.7x | 0.7x |
| Interest coverage | β | 2.0x | 2.4x | 2.2x | 1.1x | 3.2x | 6.1x | 6.2x | 6.5x | 6.3x |
| Capital allocation | ||||||||||
| Capex / revenue | β | 35.2% | 20.2% | 17.7% | 17.8% | 15.2% | 16.0% | 17.6% | 23.6% | 28.0% |
| Stock comp / revenue | β | 2.1% | 1.2% | 1.3% | 1.3% | 1.1% | 1.4% | 1.5% | 1.6% | 1.3% |
| Payouts / FCF | β | 262.5% | 153.6% | 100.5% | 94.4% | 83.7% | 109.4% | 97.2% | 154.5% | 130.3% |
| Quality scores | ||||||||||
| Accruals ratio | β | β | β | β3.5% | β4.1% | β2.7% | β1.6% | β3.1% | β3.1% | β2.4% |
Source: SEC EDGAR XBRL filings (CIK 0000910606). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.